In the news

At STAT’s AI-focused Breakthrough Summit West, Ken Stein, MD, senior vice president and global chief medical officer, shares how artificial intelligence is helping cardiologists make the leap from available insights to actionable ones.

At DeviceTalks Minnesota, Ken Stein, MD, senior vice president and global chief medical officer, outlines the steps Boston Scientific takes to evaluate a market, choose a development approach and establish the groundwork for adoption.

CEO Mike Mahoney shares lessons learned over his career that helped him shape Boston Scientific's winning culture and drive the company’s growth.

Lisa Considine, senior vice president of global talent, describes the professional development opportunities offered by Boston Scientific to early career talent that supports the company’s top ranking on Forbes’ list of America’s Best Employers for New Grads.

Dr. Michael R. Jaff, chief medical officer, Peripheral Interventions, discusses new data supporting the Eluvia™ Drug-Eluting Vascular Stent System presented at the Charing Cross Symposium. The article also explores how design elements of the device contribute to long-term outcomes in treating peripheral artery disease and future opportunities for innovation in drug-device combination therapies.